Two Swedish companies, Recipharm, a contract development and manufacturing organization (CDMO), and Adroit Science, a provider of laboratory and consultancy services, have formed a new strategic collaboration.

Adroit Science will support Recipharm's pharmaceutical development with solid state characterization services. By combining experience in formulation development, API development, chemical analysis and solid state characterization, both the speed and cost of development can be reduced while, at the same time, quality is improved. 

Carl-Johan Spak, executive vice president, development and technology at Recipharm, said, "With the addition of development services from Adroit, we will have a very competitive offering, which will help our customers to progress their projects in a highly efficient way.  Adroit Science has established itself as one of the leading providers of solid state characterization services in Northern Europe.”

"Adroit Science and Recipharm already have cooperated in a number of successful projects, and this formal partnership marks the logical next step in the mutual development of our strategic relationship," said Hans Gredeby, CEO of Adroit Science.